Free Trial

AdvisorShares Psychedelics ETF Rating

AdvisorShares Psychedelics ETF logo
$13.65 -0.37 (-2.64%)
Closing price 02/21/2025 04:10 PM Eastern
Extended Trading
$13.74 +0.08 (+0.62%)
As of 02/21/2025 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AdvisorShares Psychedelics ETF Aggregate Rating and Price Target (2025)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

PSIL Aggregate Rating

Moderate Buy
2.95

Holdings in PSIL have an aggregate rating of Moderate Buy based on 110 analyst ratings issued in the past year covering 12 companies (70.5% of the portfolio).

PSIL Aggregate Price Target

$13.65
High Prediction$13.65
Average Prediction$13.65
Low Prediction$13.65

Holdings in PSIL have an aggregate price target of $13.65 and a range of $13.65 to $13.65 covering 12 companies (70.5% of the portfolio).

PSIL Consensus Ratings of Holdings

Strong Buy
1 Strong Buy rating(s)
Buy
5 Buy rating(s)
Moderate Buy
4 Moderate Buy rating(s)
Hold
2 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by AdvisorShares Psychedelics ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 12 PSIL Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
9.38%
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
$7.63
-6.7%
2.3077 of 5 stars
3.23$26.33 245.1%13Gap Up
7.80%
Atai Life Sciences stock logo
ATAI
Atai Life Sciences
$1.99
-2.5%
3.114 of 5 stars
3.00$9.00 352.3%4Insider Trade
News Coverage
7.49%
Neuronetics, Inc. stock logo
STIM
Neuronetics
$4.13
-14.0%
1.848 of 5 stars
2.75$4.67 13.0%4
6.94%
NRx Pharmaceuticals, Inc. stock logo
NRXP
NRx Pharmaceuticals
$2.28
-6.9%
2.6644 of 5 stars
3.25$31.67 1,288.9%4
6.61%
Alkermes plc stock logo
ALKS
Alkermes
$35.33
-0.5%
3.6896 of 5 stars
2.82$38.36 8.6%11
6.32%
GH Research PLC stock logo
GHRS
GH Research
$12.51
-10.7%
2.5189 of 5 stars
3.00$30.25 141.9%4
5.53%
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
$7.31
+2.2%
4.6184 of 5 stars
2.00$9.65 32.0%20
5.41%
COMPASS Pathways plc stock logo
CMPS
COMPASS Pathways
$4.21
-7.3%
1.7 of 5 stars
3.00$30.60 626.8%6
5.04%
Intra-Cellular Therapies, Inc. stock logo
ITCI
Intra-Cellular Therapies
$128.60
+0.0%
3.916 of 5 stars
2.53$103.62 -19.4%15Earnings Report
Analyst Forecast
News Coverage
4.79%
Vistagen Therapeutics, Inc. stock logo
VTGN
Vistagen Therapeutics
$2.93
+2.1%
0.7535 of 5 stars
4.001
4.37%
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$120.69
+3.9%
4.9825 of 5 stars
2.83$166.90 38.3%23Analyst Downgrade
Buyback Announcement
Analyst Revision
Gap Up
0.84%
Relmada Therapeutics, Inc. stock logo
RLMD
Relmada Therapeutics
$0.30
-6.1%
4.3231 of 5 stars
2.00$4.25 1,340.7%5Gap Down

This page (NYSEARCA:PSIL) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners